CVS Health — Jul 31, 2025 release

ull-Year Guidance • Revised GAAP diluted EPS guidance range to $3.84 to $3.94 from $4.23 to $4.43 • Raised Adjusted EPS guidance range to $6.30 to $6.40 from $6.00 to $6.20 • Raised cash flow from operations guidance to at least $7.5 billion from approximately $7.0 billion CEO Commentary “What people want most — a connected, simpler health care experience — is what CVS Health uniquely provides. For the 185 million people we serve, we deliver better access, greater affordability and aligned advocacy. Our strong performance demonstrates the continued focus we have on operational and financial improvement across our businesses, led by a significant and durable recovery at Aetna, strong retention at CVS Caremark and growth and momentum at CVS Pharmacy.” — David Joyner, CVS Health President and CEO WOONSOCKET, RHODE ISLAND, July 31, 2025 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2025. Financial Results Summary Three Months Ended June 30, In millions, except per share amounts 2025 2024 Change Total revenues $ 98,915  $ 91,234  $ 7,681  Operating income 2,381  3,045  (664) Adjusted operating income (1) 3,808  3,744  64  Diluted earnings per share $ 0.80  $ 1.41  $ (0.61) Adjusted EPS (2) $ 1.81  $ 1.83  $ (0.02) Second quarter GAAP diluted EPS of $0.80 decreased from $1.41 in the prior year, reflecting the impact of two litigation charges associated with the Co